Jeremy Karlin, MD
Radiation Oncology · Fort Belvoir, VANPI 1083934277
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by AstraZeneca at 56.8% of the total. Reporting peaked in 2024 at $1,929 and has fallen 81.0% since, to $366 in 2025.
Across 27 payments — averaging $102.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Teleflex LLC$331
- Johnson & Johnson$282
- Bioprotect Medical, Inc.$186
- Merck$122
- KARL Storz Endoscopy-america$98
- plus $178 from 6 others
What the payments were for
- Consulting fees$1,57557%
- Food & beverage$1,19843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $1,575 |
| Teleflex LLC | 3 | $331 |
| Johnson & Johnson | 8 | $282 |
| Bioprotect Medical, Inc. | 3 | $186 |
| Merck | 2 | $122 |
| KARL Storz Endoscopy-america | 2 | $98 |
| Boston Scientific | 1 | $53 |
| Reflexion Medical, Inc. | 1 | $41 |
| Novartis | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Focal Therapeutics, Inc. | 1 | $16 |
| Medtec LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$1,575
- Barrigel$142
- RYBREVANT$116
- BIOPROTECT BALLOON IMPLANT SYSTEM$108
- LYNPARZA$106
How this compares
$2,773 in reported general payments places this provider in the 80th percentile of 121 radiation oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Fort Belvoir
- Daniel KimFairfax$406K
- Samir KananiFairfax$90K
- David PenberthyCharlottesville$67K
- Gopal BajajFairfax$23K
- Ashish ChawlaFairfax$14K
- David BuckRoanoke$13K
- Kara RomanoCharlottesville$11K
- Gregory SibleyFairfax$10K
- Anthony CrimaldiCulpeper$10K
- Kevin ChoeFairfax$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.